M&A Deal Summary |
|
---|---|
Date | 2024-04-30 |
Target | RedWave |
Sector | Technology Hardware |
Buyer(s) | 908 Devices |
Deal Type | Add-on Acquisition |
Deal Value | 54M USD |
Advisor(s) | Diamond Capital Advisors (Financial) Benesch, Friedlander, Coplan & Aronoff (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2012 |
Sector | Medical Products |
Employees | 230 |
Revenue | 50M USD (2023) |
908 Devices develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. From biopharmaceutical scientists designing life-saving medicines to responders on the front lines of public safety, its customers need immediate and actionable answers. It focuses on providing tools to help customers make decisions in minutes, not hours, days, or weeks. 908 Devices was founded in 2012 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Technology Hardware) | 1 of 1 |
Type (Add-on Acquisition) | 2 of 2 |
State (Connecticut) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2024) | 1 of 1 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-09 |
TRACE Analytics
Braunschweig, Germany TRACE Analytics develops online aseptic sampling systems and novel biosensors for bioreactor monitoring and control. Their validated technology, in single-use and reusable configurations, is applied in mammalian cell culture and microbial fermentations at all levels of the bioprocess chain, from research and development to large-scale production. TRACE Analytics was founded in 2003 and is based in Braunschweig, Germany. |
Buy | $17M |